Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 89,145

Document Document Title
WO/2015/132213A1
The present invention relates to a process for preparing terminal amino carboxylic acids and amino aldehydes from diamines using a recombinant microorganism. More particularly, the present invention relates to a process for preparing gam...  
WO/2015/133611A1
 To provide a technique of specifically reducing the quantity of target protein. Provided is a polypeptide comprising an amino acid sequence, having at least a protein region containing an amino acid sequence that specifically binds ...  
WO/2015/132411A2
Recombinant microorganisms and methods for producing saffron compounds including crocetin, crocetin dialdehyde, crocin or picrocrocin are disclosed herein.  
WO/2015/134928A3
Point of care methods to detect the probability or status of tuberculosis infection in individuals by determining presence or absence of one or more peptide of SEQ ID NOS: l-22 in a biological fluid of a subject are described. These meth...  
WO/2015/133305A1
A lipid production method that includes steps (1) and (2) and a transformant that is obtained by introducing into a host a gene that codes for protein (a) or (b). (1) A step for obtaining the transformant by introducing into the host a g...  
WO/2015/133547A1
Provided are: a γ-Glu-Val synthase suitable for producing γ-Glu-Val; and a method for producing γ-Glu-Val-Gly using said synthase. A γ-Glu-Val synthase such as a γ-Glu-Val synthase of Kocuria rosea (AJ3132), in which the ratio of γ...  
WO/2015/133116A1
When a culture medium is supplied together with a cell to a container (1) and cells are cultured, a liquid content of the container (1) is stirred by repeating an upward motion step for moving the container (1) to a position higher than ...  
WO/2015/133074A1
Provided is DNA encoding a secretion signal peptide that has high secretion capability, is capable of secreting multiple proteins and has broad utility. DNA encoding a secretion signal peptide comprising an amino acid sequence represente...  
WO/2015/132411A3
Recombinant microorganisms and methods for producing saffron compounds including crocetin, crocetin dialdehyde, crocin or picrocrocin are disclosed herein.  
WO/2015/133462A1
 Provided are: (R)-hydroxynitrile lyase which is more stable than hydroxynitrile lyase of plant origin, and which can be specifically expressed using the gene thereof; a gene that encodes said hydroxynitrile lyase; and a method for pro...  
WO/2015/134254A1
A method for treating silage to enhance the aerobic stability by increasing the fermentation and stabilization of silage by inhibiting growth of microorganisms selected from yeasts, molds and spore-forming bacteria and permitting earlier...  
WO/2015/132718A1
The present disclosure relates to an apparatus (100) for mixing multiphase flowing particles. The apparatus (100) comprises a conduit (100a) adapted to channelize the multiphase flowing particles. At least one flow diverter (101) is posi...  
WO/2015/131798A1
Provided is a nicotinamide adenine dinucleotide (NADPH)-cytochrome P450 reductase and a use thereof. Also provided is a polynucleotide encoding the NADPH-cytochrome P450 reductase, an expression vector and a host cell which express the N...  
WO/2015/132338A1
The present invention relates to a new genetically attenuated, live organism against malaria. The present invention further relates to a pharmaceutical composition comprising such live attenuated organism. The present invention further r...  
WO/2015/133590A1
Provided are: a new protein deamidase that directly acts on side chain amide groups of asparagine residues in proteins, and that has the effect of disassociating side chain carboxyl groups and ammonia; a micro-organism producing said pro...  
WO/2015/132442A1
The invention mainly relates to a polypeptide with cellulase activity for using in biomass degradation processes. The invention also relates to functional fragments of the polypeptide, and to the polynucleotides encoding said polypeptide...  
WO/2015/128795A1
The invention relates to a cell culture process for decreasing the galactosylated content and/or increasing the G0F content of a glycoprotein. The process involves subjecting recombinant cells expressing the said glycoprotein to a temper...  
WO/2015/129858A1
[Problem] To provide a bispecific antibody for the prevention or treatment of immune inflammatory diseases by acting on both human TLR2 and human TLR4, and inhibiting a human TLR2- and human TLR4-mediated immune inflammatory effect. [Sol...  
WO/2015/127596A1
Disclosed is a new bifunctional lipase mutant and uses thereof in flour product processing. An amino acid sequence of the mutant has mutations in the form of 1) or 2): 1) P298T; P298T/H317P; P298T/H317P/V326S; P298T/T218S/S234F; P298T/H3...  
WO/2015/127553A1
Disclosed is the use of a fruit kernel for producing biofuel or an intermediate in the production thereof. The fruit kernel is generally obtained from an avocado or mango and is used as a dry powder. Also disclosed are methods for produc...  
WO/2015/129651A1
The present invention provides a protein-modified IgM that overcomes problems specific to IgM, which is an oligomer antibody. Specifically, the present invention provides: modified monomeric IgM containing an IgM light chain and a modifi...  
WO/2015/129475A1
 The present invention provides a flavin-binding glucose dehydrogenase having one or more amino acid substitutions at positions corresponding to position 88 or position 554 in an amino acid sequence of SEQ ID NO: 1.  
WO/2015/130911A1
In one aspect, the present invention is directed to a dried intimate mixture comprising a fungus spore and a germinative compound, and methods for preparing the intimate mixture. In another aspect, this invention is directed to a composi...  
WO/2015/130810A3
This invention provides compositions and methods for treating and vaccinating against a HER2/neu antigen-expressing tumor and inducing an immune response against the same in a subject.  
WO/2015/128793A1
The invention describes a cell culture process for obtaining a glycoprotein composition with increased high mannose glycoforms and/or reduced galactosylated glycoforms. The method involves culturing cells producing said glycoprotein comp...  
WO/2015/130832A1
We identified 17 transcription factor genes that regulate lipid production and activity in an organism. We subsequently detailed characterization of one of them (psr1). Constructs, methods and systems for enhancing or increasing lipid pr...  
WO/2015/127527A1
The invention provides an improved modified magnetosome that contains more iron therein with the combination of the expressed genes. This is achieved by co-expression of (a) one or more bacterial magnetotactic genes to amplify iron uptak...  
WO/2015/129919A1
The present invention relates to the provision of a new pharmaceutical composition that is cancer-specific and has few side effects. The present invention provides a pharmaceutical composition including a monoclonal antibody that has hig...  
WO/2015/128461A1
The present invention relates to immunomodulator compositions and methods of use as well as methods of making. The immunomodulator compositions comprise immunostimulatory plasm ids, or DNA sequence, capable of eliciting an immune respons...  
WO/2015/125501A1
The present invention addresses the problem of providing a cryoprotectant for proteins that is highly versatile and appropriate for use in medical drugs for humans. Provided is a cryoprotectant comprising human-derived naturally denature...  
WO/2015/127305A3
The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, isoprenoids, and/or acetyl-CoA-derived products in recombinant microorganisms by engineering the microo...  
WO/2015/126112A1
The present invention relates to a method for producing 1,3-propanediol using a microorganism variant with a deletion of a 2,3-butanediol synthetic gene and, more specifically, to a variant microorganism wherein, in a microorganism havin...  
WO/2015/125904A1
[Problem] To provide an anti-human PAI-1 antibody for prevention and treatment of pulmonary fibrosis by binding to active human PAI-1 and inhibiting effects mediated by active human PAI-1. [Solution] The inventors studied anti-PAI-1 anti...  
WO/2015/127430A2
A protocol adaptive, computer controlled target-analyte permeation testing instrument, capable of self-adaptive adjustments to measurement interval, rezero frequency and independent zero go-no-go.  
WO/2015/127305A2
The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, isoprenoids, and/or acetyl-CoA-derived products in recombinant microorganisms by engineering the microo...  
WO/2015/124717A1
The invention relates to a fed-batch process for the production of bacterial ghosts based on the decoupling of the lytic gene expression and actual lysis of bacterial cells.  
WO/2015/126077A1
The present invention relates to a method for intracellular production, extraction and purification of a stable isotope-labeled protein and, more specifically, to a method for purification of a protein and analysis of the protein, the me...  
WO/2015/125849A1
 Provided is a bacteriochlorophyl b-producing variant obtained by deleting the bciA gene and bchY and/or bchZ gene inherent to a photosynthetic bacterium which produces bacteriochlorophyl a, and performing a manipulation so as to expre...  
WO/2015/120541A1
There are disclosed nucleic acid vectors for use in both gram positive and gram negative bacteria. In embodiments the vectors comprise a prokaryotic expression cassette and in embodiments comprise a eukaryotic expression cassette. In emb...  
WO/2015/121168A1
The invention relates to a yeast strain and to a method for microbial production of pentacyclic triterpenes and/or triterpenoids in yeast. More particularly, the invention relates to a modified yeast strain for production of pentacyclic ...  
WO/2015/123685A3
The present disclosure addresses biologically active formulations for agricultural and other applications that comprise a solid growth substrate that defines an open cell matrix and an active population of one or more microorganisms adhe...  
WO/2015/121863A1
The present invention provides edible vaccines comprising transgenic microalgae expressing at least one exogenous antigen or an intervening organism comprising the transgenic microalgae. The antigen expressing microalgae are used for ora...  
WO/2015/121618A1
A method of filtering microalgae from a liquid medium comprises the steps of providing a liquid medium containing microalgae, thereafter forming a hydrogel in the liquid medium, and thereafter passing the liquid medium through a filter h...  
WO/2015/122578A1
The present invention relates to a new Nephroselmis sp. novel strain and a method for increasing fatty acid content within a strain using the same. The novel strain of the present invention has a fast growth rate and contains a high cont...  
WO/2015/120542A1
There are disclosed hybrid proteins comprising at least one signal sequence; at least one DNA binding domain; and at least one cell penetrating peptide (CPP) domain. In embodiments the CPP domain is a TAT domain, and the DNA binding doma...  
WO/2015/120775A1
Provided is a recombinant strain producing L-amino acids, a constructing method therefor and a method for producing L-amino acids. Compared with the starting strains, the recombinant strain producing L-amino acids has decreased expressio...  
WO/2015/122190A1
Provided are: a method for decomposing a polyhydroxyalkanoic acid using an anaerobic microorganism flora that can decompose a polyhydroxyalkanoic acid with high efficiency to thereby convert the polyhydroxyalkanoic acid to a biogas conta...  
WO/2015/122569A1
The present invention relates to an Escherichia coli mutant strain having improved L-threonine productivity by the introduction of permease derived coryneform bacteria, and a method for producing L-threonine using the same.  
WO/2015/123409A1
The present invention is directed generally to systems for making host cells with artificial endosymbionts. In an embodiment, the systems of the invention comprise a host cell, an artificial endosymbiont, a means for introducing the arti...  
WO/2015/119219A1
The problem to be solved by the present invention is to provide a β-glucosidase, which has enzyme activity to sever the β-1,2-glucoside bond of sesaminol glycoside and which controls enzyme activity to produce sesaminol by severing the...  

Matches 651 - 700 out of 89,145